Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 6 | 2013 | 189 | 1.060 |
Why?
|
| Stroke | 3 | 2013 | 340 | 0.670 |
Why?
|
| Brain | 8 | 2013 | 1472 | 0.660 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2009 | 78 | 0.640 |
Why?
|
| Gemfibrozil | 2 | 2010 | 2 | 0.640 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 269 | 0.580 |
Why?
|
| PPAR alpha | 2 | 2011 | 42 | 0.410 |
Why?
|
| Cerebrovascular Circulation | 2 | 2009 | 70 | 0.370 |
Why?
|
| Microvessels | 1 | 2010 | 31 | 0.330 |
Why?
|
| Middle Cerebral Artery | 2 | 2009 | 14 | 0.320 |
Why?
|
| Reperfusion Injury | 3 | 2009 | 58 | 0.320 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 158 | 0.310 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 146 | 0.310 |
Why?
|
| Blood-Brain Barrier | 2 | 2009 | 173 | 0.310 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 140 | 0.310 |
Why?
|
| Brain Infarction | 1 | 2009 | 22 | 0.310 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 239 | 0.300 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 79 | 0.300 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2009 | 95 | 0.290 |
Why?
|
| Mice | 10 | 2011 | 6644 | 0.280 |
Why?
|
| Ischemia | 1 | 2008 | 47 | 0.270 |
Why?
|
| Retina | 1 | 2008 | 289 | 0.230 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 66 | 0.200 |
Why?
|
| Stilbenes | 1 | 2003 | 44 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 4 | 2011 | 1869 | 0.200 |
Why?
|
| Huntington Disease | 1 | 2002 | 31 | 0.190 |
Why?
|
| Kainic Acid | 1 | 2002 | 48 | 0.190 |
Why?
|
| Animals | 10 | 2011 | 16992 | 0.190 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2002 | 33 | 0.180 |
Why?
|
| Brain Edema | 1 | 2002 | 64 | 0.180 |
Why?
|
| Corpus Striatum | 1 | 2002 | 121 | 0.170 |
Why?
|
| Neuroglia | 1 | 2002 | 133 | 0.170 |
Why?
|
| Glutamic Acid | 1 | 2002 | 131 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2009 | 75 | 0.150 |
Why?
|
| Triglycerides | 2 | 2009 | 147 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2003 | 735 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2010 | 1035 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 652 | 0.140 |
Why?
|
| Cholesterol | 2 | 2009 | 232 | 0.130 |
Why?
|
| Male | 8 | 2011 | 23409 | 0.130 |
Why?
|
| Gene Expression | 2 | 2009 | 701 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1271 | 0.110 |
Why?
|
| Neurons | 1 | 2002 | 1263 | 0.110 |
Why?
|
| Injections, Intraventricular | 2 | 2011 | 59 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 39 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2010 | 55 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2011 | 139 | 0.080 |
Why?
|
| Antipyrine | 1 | 2009 | 4 | 0.080 |
Why?
|
| Autoradiography | 1 | 2009 | 37 | 0.080 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 6 | 0.080 |
Why?
|
| Cerebral Infarction | 1 | 2009 | 19 | 0.080 |
Why?
|
| Transplantation Chimera | 1 | 2009 | 6 | 0.080 |
Why?
|
| Capillaries | 1 | 2009 | 27 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 19 | 0.080 |
Why?
|
| Gelatinases | 1 | 2009 | 9 | 0.080 |
Why?
|
| Capillary Permeability | 1 | 2009 | 36 | 0.080 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2009 | 13 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2009 | 100 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 62 | 0.070 |
Why?
|
| Body Temperature | 1 | 2009 | 35 | 0.070 |
Why?
|
| Amaurosis Fugax | 1 | 2008 | 1 | 0.070 |
Why?
|
| Isoflurane | 1 | 2008 | 3 | 0.070 |
Why?
|
| Models, Anatomic | 1 | 2008 | 18 | 0.070 |
Why?
|
| Aorta | 1 | 2009 | 198 | 0.070 |
Why?
|
| Microspheres | 1 | 2008 | 49 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 138 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 110 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 256 | 0.070 |
Why?
|
| RNA | 1 | 2009 | 266 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 719 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 1596 | 0.060 |
Why?
|
| Time Factors | 1 | 2009 | 1857 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2009 | 1604 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2010 | 1003 | 0.050 |
Why?
|
| Haplorhini | 1 | 2003 | 23 | 0.050 |
Why?
|
| alpha-Macroglobulins | 1 | 2003 | 1 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 83 | 0.050 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2002 | 1 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 1 | 2002 | 22 | 0.050 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2002 | 33 | 0.050 |
Why?
|
| Calpain | 1 | 2002 | 35 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2002 | 18 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2002 | 36 | 0.050 |
Why?
|
| Cattle | 1 | 2003 | 498 | 0.050 |
Why?
|
| Caspases | 1 | 2002 | 148 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2002 | 57 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2002 | 227 | 0.040 |
Why?
|
| Amides | 1 | 2002 | 71 | 0.040 |
Why?
|
| Cell Death | 1 | 2002 | 278 | 0.040 |
Why?
|
| Astrocytes | 1 | 2003 | 244 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1124 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 333 | 0.040 |
Why?
|
| Apoptosis | 1 | 2008 | 1568 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 386 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2003 | 329 | 0.040 |
Why?
|
| Humans | 3 | 2013 | 43102 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 1 | 2003 | 5 | 0.010 |
Why?
|
| Osmosis | 1 | 2003 | 9 | 0.010 |
Why?
|
| Mannitol | 1 | 2003 | 11 | 0.010 |
Why?
|
| Permeability | 1 | 2003 | 67 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 78 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 109 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 2002 | 19 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2002 | 16 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 67 | 0.010 |
Why?
|
| Peroxidase | 1 | 2002 | 57 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2003 | 182 | 0.010 |
Why?
|
| Leukocytes | 1 | 2002 | 80 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 280 | 0.010 |
Why?
|
| Female | 1 | 2002 | 24698 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 140 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 934 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 1621 | 0.010 |
Why?
|